IHS Chemical Week

People & Business :: People/Executives

Cambrex appoints former Teva CEO as board vice chairman

6:53 AM MST | November 29, 2012 | Deepti Ramesh

Cambrex (East Rutherford, NJ) says it has appointed Shlomo Yanai to its board of directors and will serve as its non-executive vice chairman.  Yanai was the president and CEO of Teva Pharmaceutical Industries (Petach Tikva, Israel), the largest generic pharmaceutical manufacturer in the world, until his retirement in mid-2012. As vice chairman of the Cambrex board, he will work closely with the company's other directors and its leadership team to formulate and help execute Cambrex's growth strategies, the company says. “Shlomo's outstanding background...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa